Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pleural Effusion, Malignant × Saline Solution × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 26 Pain, Postoperative 17 Neoplasms 13 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Lung Neoplasms 12 Brain Neoplasms 10 Prostatic Neoplasms 9 Ovarian Neoplasms 9 Colorectal Neoplasms 7 Colonic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Carcinoma, Hepatocellular 7 Depression 6 Thyroid Neoplasms 5 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Head and Neck Neoplasms 5 Pain 4 Multiple Myeloma 4 Lymphoma 4 Leiomyoma 4 Anxiety Disorders 4 Urinary Bladder Neoplasms 3 Thromboembolism 3 Supratentorial Neoplasms 3 Stomatitis 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Myofibroma 3 Lymphoma, Non-Hodgkin 3

Interventions

Cisplatin 8 Carboplatin 7 Bevacizumab 7 Talc 6 Pleurodesis 6 Paclitaxel 5 Doxycycline 4 Docetaxel 4 Thoracoscopy 3 Taxes 3 Gemcitabine 3 Zoledronic Acid 2 Trastuzumab 2 Thoracentesis 2 Surveys and Questionnaires 2 Sodium Chloride 2 Silver Nitrate 2 Povidone-Iodine 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 High-Energy Shock Waves 2 Fluorodeoxyglucose F18 2 Fentanyl 2 Erlotinib Hydrochloride 2 Drug Therapy 2 Chest Tubes 2 Bortezomib 2 viscum album peptide 1 tocilizumab 1 tipifarnib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01411202 2020-09-25

OPUS

Ottawa Hospital Research Institute

Phase 2 Unknown

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡